Effects of Antimicrobial Prophylaxis on Asymptomatic Bacteriuria and Predictors of Failure in Patients with Multiple Sclerosis

REFERENCES

• Fowler CJ. The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis. Baillieres Clin Neurol 1997; 6: 447–466.
   PubMedGoogle Scholar
• Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SCW, Kirby M, et al. A UK consensus on the management of the bladder in multiple scle-rosis. J Neurol Neurosurg Psychiatry 2009; 80: 470–477.
   PubMed Web of Science ®Google Scholar
• Nortvedt MW, Rlise T, Frugard J, et al. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. MuIt Scler 2007; 13: 106–112.
   PubMed Web of Science ®Google Scholar
• Hinson JL, Boone TB. Urodynamics and multiple sclerosis. Urol Clin North Am 1996; 23: 475–481.
   PubMed Web of Science ®Google Scholar
• Gallien P, Robineau S, Nicolas, Le Bot MP, Brissot R, Verin M. Vesi-courethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil 1998; 79: 255–257.
   PubMed Web of Science ®Google Scholar
• Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neu-rological features of bladder dysfunction in multiple sclerosis. J Neurol Neu-rosurg Psychiatry 1993; 56: 245–250.
   PubMed Web of Science ®Google Scholar
• Kalsi V, Fowler CJ. Therapy Insight: bladder dysfunction associated with multiple sclerosis. Nat Clin Pract Urol 2005; 2: 492–501.
   PubMedGoogle Scholar
• Wahlquist GI, Booss J. Bacteriuria in multiple sclerosis: documentation by prospective cultures. Conn Med 1987; 51: 766–768.
   PubMedGoogle Scholar
• Edlich RF, Westwater JJ, Lombardi SA, Watson LR, Howards SS. Mul-tiple sclerosis and asymptomatic urinary tract infection. J Emery Med 1990; 8: 25–28.
   PubMedGoogle Scholar
• Fleming ST, Blake RLJr. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol 1994; 10: 1127–1132.
   Web of Science ®Google Scholar
• Metz LM, McGuinness SD, Harris C. Urinary tract infections may trig-ger relapse in multiple sclerosis. Axone 1998; 19: 67–70.
   PubMedGoogle Scholar
• Rapp NS, Gilroy J, Lerner AM. Role of bacterial infection in exacer-bation of multiple sclerosis. Am J Phys Med Rehabil 1995; 74: 415–418.
   PubMed Web of Science ®Google Scholar
• Fowler CJ. Investigation of the neurogenic bladder. J Neurol Neuro-surg Psychiatry 1996; 60: 6–13.
   PubMed Web of Science ®Google Scholar
• Kornhuber HH, Schutz A. Efficient treatment of neurogenic bladder disorders in multiple sclerosis with initial intermittent catheterization and ul-trasound-controlled training. Eur Neurol 1990; 30: 260–267.
   PubMed Web of Science ®Google Scholar
• Oakeshott P, Hunt GM. Intermittent self catheterization for patients with urinary incontinence or difficulty emptying the bladder. Br J Gen Pract 1992; 42: 253–255.
   PubMed Web of Science ®Google Scholar
• Lapides J, Diokno AC, Gould FR, Lowe BS. Further observations on self-catheterization. J Urol 1976; 116: 169–171.
   PubMed Web of Science ®Google Scholar
• Shokeir AA, Al Ansari AA. Iatrogenic infections in urological prac-tice: concepts of pathogenesis, prevention and management. Scand J Urol Nephrol 2006; 40: 89–97.
   PubMed Web of Science ®Google Scholar
• Blok BF, Karsenty G, Corcos J. Urological surveillance and management of patients with neurogenic bladder: Results of a survey among prac-ticing urologists in Canada. Can J Urol 2006; 13: 3239–3243.
   PubMedGoogle Scholar
• Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gail-lard JL, et al. Prevention of urinary tract infection in spinal cord-injured Patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up-an observational prospective study. J Antimicrob Chemother 2006; 57: 784–788.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an ex-panded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bac-teriuria in adults. Am Fam Physician 2006; 74: 985–990.
   PubMed Web of Science ®Google Scholar
• Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin BH, Mont-gomerie J, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129–138.
   PubMed Web of Science ®Google Scholar
• Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treat-ment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643–654.
   PubMed Web of Science ®Google Scholar
• Kragt JJ, Hoogervorst EL, Uitdehaag BM, Polman CH. Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis. Neurology 2004; 63: 1716–1718.
   PubMed Web of Science ®Google Scholar
• Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal cord 2002; 40: 536–541.
   PubMed Web of Science ®Google Scholar
• Bakke A, Digranes A. Bacteriuria in patients treated with clean inter-mittent catheterization. Scand J Infect Dis 1991; 23: 577–582.
   PubMed Web of Science ®Google Scholar
• Bakke A, Hoisaeter PA. Clean intermittent catheterization in lower urinary tract dysfunction-an overview. Scand J Urol Nephrol Suppl 1994; 157: 55–60.
   PubMedGoogle Scholar
• Bakke A, Vollset SE. Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. J Urol 1993; 149: 527–531.
   PubMed Web of Science ®Google Scholar
• Waites KB, Canupp KC, DeVivo MJ. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil 1993; 74: 691–695.
   PubMed Web of Science ®Google Scholar
• Webb RJ, Lawson AL, Neal DE. Clean intermittent self-catheterisation in 172 adults. Br J Urol 1990; 65: 20–23.
   PubMedGoogle Scholar
• Waites KB, Canupp KC, DeVivo MJ. Eradication of urinary tract in-fection following spinal cord injury. Paraplegia 1993; 31: 645–652.
   PubMedGoogle Scholar
• Pedersen SS, Horbov S, Biering-Sorensen F, Hoiby N. Peroral treat-ment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria. Paraplegia 1990; 28: 41–47.
   PubMedGoogle Scholar
• Stannard AJ, Sharpies SJ, Norman PM, Tillotson GS. Ciprofloxacin therapy of urinary tract infections in paraplegic and tetraplegic patients: a bacteriological assessment. J Antimicrob Chemother 1990;26 (Suppl 19: 13–18.
   PubMedGoogle Scholar
• Waites KB, Canupp KC, DeVivo MJ. Efficacy and tolerance of nor-floxacin in treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injury. Urology 1991; 38: 589–596.
   PubMed Web of Science ®Google Scholar
• Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol 1984; 132:943946.
   Google Scholar
• Van Poppel H, Baert L. Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis. Pharm Weekbl Sci 1987; 9 (Suppl):576-77.
   Google Scholar
• Van Poppel H, Wegge M, Dammekens H, Chysky V. Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis. Eur J Clin Microbiol 1986; 5: 251–253.
   PubMedGoogle Scholar
• Schlager TA, Anderson S, TrudeII J, Hendley JO. Nitrofurantoin pro-phylaxis for bacteriuria and urinary tract infection in children with neuro-genic bladder on intermittent catheterization. J Pediatr 1998; 132: 704–708.
   PubMed Web of Science ®Google Scholar